Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Solomon

Showing results (931-940 of 1,873) with videos related to

Pageof 188
Sort By:
Lancet (London, England)|August 31, 2012
The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trialScott D Solomon, Michael Zile, Burkert Pieske, et al.
European Journal of Medical Genetics|July 4, 2012
GWAS reveals new recessive loci associated with non-syndromic facial cleftingMauricio Camargo, Dora Rivera, Lina Moreno, et al.
European Journal of Heart Failure|February 7, 2024
Impact of vutrisiran on exploratory cardiac parameters in hereditary transthyretin-mediated amyloidosis with polyneuropathyPablo Garcia-Pavia, Martha Grogan, Parag Kale, et al.
American Heart Journal|May 24, 2025
Structural abnormalities and effects of sacubitril/valsartan in patients with mildly reduced or preserved ejection fraction and worsening heart failure: The PARAGLIDE-HF trialVeraprapas Kittipibul, Derek D Cyr, Josephine Harrington, et al.
JAMA Cardiology|May 22, 2023
Age Dependency of Cardiovascular Outcomes With the Amyloidogenic pV142I Transthyretin Variant Among Black Individuals in the USSenthil Selvaraj, Brian L Claggett, C Cristina Quarta, et al.
Journal of the American College of Cardiology|May 30, 2020
Fewer Hospitalizations for Acute Cardiovascular Conditions During the COVID-19 PandemicAnkeet S Bhatt, Alea Moscone, Erin E McElrath, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 25, 2010
Dialysis practices that distinguish top- versus bottom-performing facilities by hemoglobin outcomesBrennan M R Spiegel, Roger Bolus, Amar A Desai, et al.
Circulation|June 23, 2017
Physical Activity and Prognosis in the TOPCAT Trial (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist)Sheila M Hegde, Brian Claggett, Amil M Shah, et al.
Journal of the American College of Cardiology|September 25, 2007
The relationship between renal function and cardiac structure, function, and prognosis after myocardial infarction: the VALIANT Echo StudyAnil Verma, Nagesh S Anavekar, Alessandra Meris, et al.
Circulation|May 25, 2011
Circumstances and outcomes of sudden unexpected death in patients with high-risk myocardial infarction: implications for preventionSiqin Ye, Matthew Grunnert, Jens Jakob Thune, et al.
Pageof 188

Showing results (931-940 of 1,873) with videos related to

Sort By:
Pageof 188
Lancet (London, England)|August 31, 2012
The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trialScott D Solomon, Michael Zile, Burkert Pieske, et al.
European Journal of Medical Genetics|July 4, 2012
GWAS reveals new recessive loci associated with non-syndromic facial cleftingMauricio Camargo, Dora Rivera, Lina Moreno, et al.
European Journal of Heart Failure|February 7, 2024
Impact of vutrisiran on exploratory cardiac parameters in hereditary transthyretin-mediated amyloidosis with polyneuropathyPablo Garcia-Pavia, Martha Grogan, Parag Kale, et al.
American Heart Journal|May 24, 2025
Structural abnormalities and effects of sacubitril/valsartan in patients with mildly reduced or preserved ejection fraction and worsening heart failure: The PARAGLIDE-HF trialVeraprapas Kittipibul, Derek D Cyr, Josephine Harrington, et al.
JAMA Cardiology|May 22, 2023
Age Dependency of Cardiovascular Outcomes With the Amyloidogenic pV142I Transthyretin Variant Among Black Individuals in the USSenthil Selvaraj, Brian L Claggett, C Cristina Quarta, et al.
Journal of the American College of Cardiology|May 30, 2020
Fewer Hospitalizations for Acute Cardiovascular Conditions During the COVID-19 PandemicAnkeet S Bhatt, Alea Moscone, Erin E McElrath, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 25, 2010
Dialysis practices that distinguish top- versus bottom-performing facilities by hemoglobin outcomesBrennan M R Spiegel, Roger Bolus, Amar A Desai, et al.
Circulation|June 23, 2017
Physical Activity and Prognosis in the TOPCAT Trial (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist)Sheila M Hegde, Brian Claggett, Amil M Shah, et al.
Journal of the American College of Cardiology|September 25, 2007
The relationship between renal function and cardiac structure, function, and prognosis after myocardial infarction: the VALIANT Echo StudyAnil Verma, Nagesh S Anavekar, Alessandra Meris, et al.
Circulation|May 25, 2011
Circumstances and outcomes of sudden unexpected death in patients with high-risk myocardial infarction: implications for preventionSiqin Ye, Matthew Grunnert, Jens Jakob Thune, et al.
Pageof 188